Adjuvant Chemotherapy in India

Adjuvant chemotherapy in India is chemotherapy given after the primary treatment of cancer — most commonly after surgery — to destroy microscopic cancer cells that may remain in the body and reduce the risk of cancer returning. Whether it is appropriate depends on the type and stage of cancer, pathology results, lymph-node involvement, molecular or biomarker findings, the treatment already received, and the patient's overall health.

There is a named GAF Healthcare partner planning sheet for adjuvant chemotherapy: $2,500–$10,000, typically cycles after surgery · 3–6 months. Neighbouring United States comparison figures on the same sheet are $15,000–$45,000. That India band is a pathway planning range for oncology review, post-operative cycles and associated day-care. It is not the price of a single infusion and it is not a whole-cancer package.

Neighbouring neoadjuvant chemotherapy is $2,500–$10,000, typically cycles before surgery · 2–4 months. Neighbouring chemotherapy is $1,500–$8,000+, typically outpatient cycles over 3–6 months. Named chemotherapy lists sit on Chemotherapy in India. Neighbouring palliative chemotherapy is $1,500–$7,000. Neighbouring immunotherapy is $15,000–$45,000. Neighbouring targeted therapy is $8,000–$30,000. Neighbouring molecular targeted therapy is $10,000–$32,000. Neighbouring hormone therapy is $1,000–$4,500. Neighbouring precision oncology is $2,000–$7,000. Neighbouring maintenance therapy is $4,000–$18,000. Neighbouring intraperitoneal chemotherapy is $5,000–$14,000.

Disease pathways sit on breast cancer treatment in India, colon cancer treatment in India, ovarian cancer treatment in India, pancreatic cancer treatment in India and bile duct cancer surgery in India. Radiation lists sit on external beam radiotherapy in India. There is no live GAF lung-cancer-only, gastric-cancer-only, endometrial-only or sarcoma-only treatment page.

Important: Adjuvant chemotherapy is a specialised oncology plan. The actual hospital quotation depends on cancer type, regimen, number of cycles, branded versus generic medicines, port placement, supportive care and whether targeted therapy or radiation is also required. A quotation should be obtained only after records review.

What is adjuvant chemotherapy?

Cancer surgery can remove all cancer that is visible on imaging or during an operation. Individual cancer cells or very small clusters of cells may remain elsewhere in the body and may not be detectable using currently available tests.

Adjuvant chemotherapy is designed to treat this potential microscopic residual disease.

Chemotherapy drugs work in different ways. Many conventional chemotherapy medicines interfere with the ability of rapidly dividing cells to grow, divide or repair themselves. Because some healthy cells also divide rapidly, chemotherapy can affect normal tissues and cause side effects.

The purpose of adjuvant treatment is therefore not necessarily to treat a visible tumour. Instead, it is intended to reduce the probability that microscopic cancer cells will eventually develop into a clinically detectable recurrence.

Why is it given after surgery?

Surgery is a local treatment. It removes the known tumour and, depending on the cancer, may also remove nearby lymph nodes or other affected tissue.

Chemotherapy is systemic. It circulates through the bloodstream and can reach cancer cells in different parts of the body.

A patient may have a successful operation, no visible cancer on postoperative scans, clear or negative surgical margins and no obvious distant metastases, and still have a risk of microscopic disease.

Adjuvant chemotherapy may therefore be recommended when clinical evidence shows that systemic treatment can lower the risk of recurrence for that particular cancer and risk group.

The decision is a balance between the potential reduction in recurrence risk and the possible short- and long-term effects of chemotherapy.

Adjuvant versus neoadjuvant chemotherapy

The terms are often confused.

Feature	Neoadjuvant chemotherapy	Adjuvant chemotherapy
When is it given?	Before definitive surgery or another local treatment	After primary treatment, commonly surgery
Main objective	Shrink or control the tumour before local treatment	Reduce the risk of recurrence after local treatment
Can tumour response be assessed?	Often yes, because the tumour is still present	Usually based on pathology, cancer risk and follow-up
GAF Healthcare India planning	$2,500–$10,000	$2,500–$10,000
Typical stay on the cost sheet	Cycles before surgery · 2–4 months	Cycles after surgery · 3–6 months

The correct sequence depends on the individual cancer. Neighbouring neoadjuvant chemotherapy is a different sheet and is not an adjuvant quotation. Named pre-operative lists sit on Neoadjuvant Chemotherapy in India.

Which cancers may require adjuvant chemotherapy?

Adjuvant chemotherapy is used in several cancers, but not every patient with the same cancer will receive it.

Breast cancer

Adjuvant chemotherapy may be recommended after breast-cancer surgery when the risk of recurrence is sufficiently high. The decision may consider tumour size, lymph-node involvement, grade, hormone-receptor status, HER2 status, age, menopausal status, genomic testing where appropriate and previous treatment.

Some patients may also receive endocrine therapy, anti-HER2 treatment, radiation or other systemic therapies. See breast cancer treatment in India and chemotherapy for breast cancer. Named endocrine-therapy lists sit on Hormone Therapy in India.

Colon cancer

Adjuvant chemotherapy is an important component of treatment for many patients with resected colon cancer, particularly those with stage III disease. Common approaches can include fluoropyrimidine-based treatment, sometimes combined with oxaliplatin, including FOLFOX or CAPOX. See colon cancer treatment in India and colon cancer chemotherapy.

Rectal cancer

Rectal-cancer treatment frequently involves carefully planned combinations of chemotherapy, radiation and surgery. The sequence can differ from colon cancer. There is no live GAF rectal-cancer treatment page; the named surgical sheet is rectal cancer surgery.

Ovarian cancer

Chemotherapy is an important component of treatment for many epithelial ovarian cancers. In patients with operable disease, chemotherapy may be given after surgery or incorporated into a broader sequence. Platinum-based combinations are commonly used. See ovarian cancer treatment in India. Neighbouring intraperitoneal chemotherapy is a different regional route.

Endometrial cancer

Some patients with endometrial cancer may receive chemotherapy after surgery depending on stage, histological type, grade, molecular characteristics, lymph-node status and recurrence risk. There is no live GAF endometrial-cancer-only treatment page.

Gastric cancer

For stomach cancer, chemotherapy may be incorporated before and/or after surgery depending on stage, surgical approach and protocol. There is no live GAF gastric-cancer-only treatment page.

Pancreatic cancer

Patients who undergo potentially curative pancreatic-cancer surgery may be considered for postoperative systemic chemotherapy. See pancreatic cancer treatment in India and Whipple surgery in India.

Biliary-tract cancer

Adjuvant chemotherapy can be considered after surgical resection of selected biliary-tract cancers. See bile duct cancer surgery in India.

Lung cancer and other cancers

Selected patients with resected non-small-cell lung cancer, selected sarcomas and other malignancies may receive adjuvant systemic therapy when evidence supports it. There is no live GAF lung-cancer-only or sarcoma-only treatment page.

Who is a candidate?

There is no single test that determines whether every cancer patient needs adjuvant chemotherapy.

The medical-oncology team usually considers stage, the final pathology report, lymph-node involvement, molecular and biomarker findings, and overall health.

Important pathology features may include histological type, tumour grade, tumour size, lymphovascular invasion, perineural invasion, surgical margins, number of lymph nodes examined and biomarker findings.

Depending on the cancer, testing may include hormone receptors, HER2, EGFR, ALK, ROS1, BRAF, MSI/MMR, KRAS/NRAS, PD-L1 and other molecular alterations. Not every biomarker is relevant to every cancer. Neighbouring precision oncology is $2,000–$7,000. Named genomic-testing lists sit on Precision Oncology in India.

Doctors may also assess kidney function, liver function, blood counts, heart function, nutritional status, performance status, existing medical conditions and previous cancer treatment.

When may it not be suitable?

Adjuvant chemotherapy may not be appropriate when the expected reduction in recurrence risk is small, surgical recovery is incomplete, organ function is limited, frailty is substantial, or an alternative targeted or endocrine plan is the better evidence-based option.

Patients should not start or delay chemotherapy based on a generic timeline found online. The postoperative treatment window should be discussed with the treating oncology team.

How is adjuvant chemotherapy planned in India?

Step 1: Complete cancer diagnosis

The diagnosis and extent of disease are established using pathology, imaging and other relevant investigations.

Step 2: Primary treatment

This may include surgery or another definitive treatment.

Step 3: Final pathology review

The surgical specimen is examined to establish the final pathological stage and risk characteristics.

Step 4: Multidisciplinary review

Depending on the cancer, specialists may discuss the case in a tumour board.

Step 5: Adjuvant treatment decision

The oncologist evaluates the potential benefits and risks of postoperative systemic treatment.

Step 6: Pre-chemotherapy assessment

Blood tests and other assessments confirm that the patient can safely begin treatment.

Step 7: Chemotherapy

Treatment is administered according to the prescribed protocol.

Step 8: Monitoring

Blood counts, kidney and liver function, symptoms and treatment tolerance are monitored throughout therapy.

Step 9: Completion and follow-up

After the planned treatment, the patient enters a surveillance and survivorship programme.

What drugs and regimens are used?

There is no universal adjuvant chemotherapy drug. The medicines depend on the cancer.

Common chemotherapy medicines used in different settings include 5-fluorouracil, capecitabine, oxaliplatin, cisplatin, carboplatin, paclitaxel, docetaxel, doxorubicin, cyclophosphamide, gemcitabine, irinotecan, etoposide and vinorelbine. These medicines may be used alone or in combinations.

Regimen	Commonly associated cancer settings
FOLFOX	Colorectal and selected gastrointestinal cancers
CAPOX / CAPEOX	Colorectal and selected gastrointestinal cancers
AC or AC-T	Selected breast-cancer settings
TC	Selected breast-cancer settings
Paclitaxel plus carboplatin	Ovarian and selected gynaecological cancers
Gemcitabine-based regimens	Selected pancreatic and other cancers
Cisplatin-based regimens	Several cancer types

These are examples rather than prescriptions. The same cancer can have several evidence-based options depending on stage, pathology, biomarkers, age, organ function and current guidelines.

How many cycles are needed?

The number of cycles varies widely. A cycle consists of treatment followed by a recovery period.

Some protocols may be administered weekly, every two weeks, every three weeks, every four weeks or on another individualised schedule.

The total number of cycles is determined by the cancer type, evidence supporting the treatment, regimen, tolerance and the patient's individual circumstances.

Patients should ask how many cycles are planned, how long each cycle is, whether hospitalisation is required, what blood tests are needed, what happens if blood counts are low, and which symptoms require urgent medical attention.

How is it given?

Depending on the medicine, chemotherapy may be given through intravenous infusion, oral tablets or capsules, or a combination. Capecitabine is one example of an oral chemotherapy drug used in selected cancers.

Patients receiving repeated intravenous treatment may sometimes require a port or another form of central venous access.

A typical outpatient visit may include registration, blood tests, weight and vital-sign assessment, oncology review, dose confirmation, premedications, infusion or oral treatment, observation and discharge instructions. Some sessions take several hours. Some patients require inpatient treatment.

Side effects

Chemotherapy can affect healthy cells as well as cancer cells. Not every patient experiences every side effect, and severity varies.

Common side effects can include fatigue, nausea, vomiting, loss of appetite, hair loss, mouth sores, diarrhoea, constipation, low white-cell counts, anaemia, low platelet counts, increased infection risk, taste changes, skin or nail changes, peripheral neuropathy, menstrual or reproductive changes, fertility problems and changes in concentration or memory.

Some chemotherapy drugs suppress bone marrow activity and can lower neutrophils. A fever during chemotherapy can require urgent medical assessment, particularly when associated with neutropenia.

If fever, shaking chills, uncontrolled vomiting, chest pain, breathlessness, collapse or rapidly worsening infection develops, seek a local emergency department immediately. Do not wait for the next scheduled chemotherapy appointment or use WhatsApp as emergency care.

Fertility, work and nutrition

Certain chemotherapy drugs can affect reproductive function in both women and men. Patients who may want biological children should discuss fertility preservation before chemotherapy starts whenever possible.

Some patients continue working during chemotherapy, while others need reduced hours or time away from work. The answer depends on the regimen, side effects, occupation, infection exposure and individual response.

Good nutrition can help patients maintain strength. Patients should be cautious about taking herbal products, high-dose vitamins or supplements without informing their oncologist.

Adjuvant chemotherapy with radiation, targeted therapy or immunotherapy

Chemotherapy and radiation therapy may both be used after surgery in selected cancers. The sequence varies. See external beam radiotherapy in India.

Chemotherapy is different from targeted therapy and from immunotherapy. Some patients receive chemotherapy together with targeted treatment, while others receive targeted therapy sequentially or instead of conventional chemotherapy. Named molecular-matched lists sit on Molecular Targeted Therapy in India. Neighbouring targeted therapy is $8,000–$30,000. Neighbouring immunotherapy is $15,000–$45,000. Neighbouring hormone therapy is $1,000–$4,500.

Patients should ask about the complete postoperative treatment plan, rather than viewing chemotherapy in isolation.

How is success measured?

If the visible tumour has already been removed, there may be no measurable tumour to monitor during treatment. The objective is usually to reduce recurrence risk.

Follow-up may involve physical examination, blood tests, tumour markers in selected cancers, imaging when clinically indicated, colonoscopy for colorectal cancer, mammography where appropriate and monitoring for late treatment effects.

Adjuvant chemotherapy cannot guarantee that cancer will never return. If cancer returns, the next treatment depends on where it has returned and the biology of the cancer.

Cost of adjuvant chemotherapy in India

There is no medically reliable single price for all patients. GAF Healthcare partner planning for the named adjuvant chemotherapy pathway is $2,500–$10,000, typically cycles after surgery over 3–6 months. Neighbouring United States comparison figures are $15,000–$45,000.

The final hospital quotation can depend on cancer type, regimen, individual drug doses, body-surface area, number of cycles, generic or branded medicines, oral versus intravenous treatment, day-care or inpatient administration, hospital charges, port placement, blood tests, imaging, anti-nausea medicines, growth-factor injections, management of side effects and complications.

When comparing hospitals, ask whether the quotation includes oncologist consultation, chemotherapy drugs, infusion charges, day-care charges, nursing, pre-chemotherapy blood tests, premedications, anti-nausea medicines, growth factors if prescribed, a central venous port if required, emergency care and management of treatment complications.

A very low initial quotation may not represent the final treatment cost if supportive medicines and investigations are excluded.

Adjuvant chemotherapy cost by Indian city

There is no reliable single national tariff. GAF Healthcare uses one national partner planning band of $2,500–$10,000 rather than inventing city-specific prices.

International patients comparing medical oncologists listing Adjuvant Chemotherapy commonly start with Delhi NCR, Mumbai, Bengaluru, Chennai and Hyderabad. Partner medical oncology hospitals in Delhi NCR, Mumbai and Bengaluru, and in Chennai and Hyderabad, are a typical first filter. City sheets include Delhi NCR, Mumbai, Bengaluru, Chennai and Hyderabad. Pune, Kolkata, Ahmedabad, Kochi, Jaipur, Chandigarh, Lucknow and Indore are not live GAF catalog cities on this site.

City	Catalogue doctors list	India planning band
Delhi NCR	Medical oncologists listing Adjuvant Chemotherapy	$2,500–$10,000
Mumbai	Medical oncologists listing Adjuvant Chemotherapy	$2,500–$10,000
Bengaluru	Medical oncologists listing Adjuvant Chemotherapy	$2,500–$10,000
Chennai	Medical oncologists listing Adjuvant Chemotherapy	$2,500–$10,000
Hyderabad	Medical oncologists listing Adjuvant Chemotherapy	$2,500–$10,000

How to choose a centre

The right hospital depends on the patient's specific cancer rather than simply choosing the largest hospital.

A strong postoperative cancer programme should have medical oncology, surgical oncology, radiation oncology, expert pathology, molecular diagnostics, radiology, cancer-specific multidisciplinary teams, chemotherapy day-care facilities, emergency support, blood-bank access, nutrition services, pain and supportive care, infection management, fertility counselling where appropriate, and survivorship follow-up.

Why consider India?

International patients may consider India when they require complex cancer treatment, multidisciplinary oncology services or access to specialist cancer centres.

Factors that may influence the decision include availability of medical-oncology specialists, multidisciplinary cancer care, access to surgical oncology and radiation oncology, pathology and molecular testing, chemotherapy day-care facilities, supportive oncology services and international-patient coordination.

Documents to send before travel

For an oncology consultation, patients should ideally provide biopsy and surgical pathology reports, discharge summaries, previous oncology notes, chemotherapy and radiation records, CT/MRI/PET-CT reports and imaging files, complete blood count, kidney and liver function, relevant tumour markers, and molecular reports where relevant.

Having the complete medical record can help the treating team make a more informed assessment before the patient travels.

Questions to ask before starting treatment

1. Why do I need adjuvant chemotherapy?
2. What is my risk of recurrence without it, and how much could chemotherapy reduce that risk?
3. What regimen do you recommend, and why?
4. How many cycles will I need, and how long will the entire treatment take?
5. What are the most likely side effects, and which require emergency care?
6. Will I need a chemotherapy port?
7. Will treatment affect fertility?
8. Do I need molecular or genetic testing?
9. What follow-up will I need after chemotherapy?
10. What is the estimated total treatment cost, and which costs are included?

Frequently asked questions

Is adjuvant chemotherapy the same as chemotherapy?

Adjuvant chemotherapy is a specific use of chemotherapy. It is given after the primary treatment, usually surgery, to reduce the risk of recurrence.

Is it always necessary after cancer surgery?

No. Some patients do not benefit enough from postoperative chemotherapy to justify its risks. The decision depends on cancer type, stage, pathology, biomarkers and individual recurrence risk.

Is it given before or after surgery?

Adjuvant chemotherapy is given after the primary treatment. Chemotherapy given before surgery is generally called neoadjuvant chemotherapy.

How soon after surgery can chemotherapy start?

There is no universal timetable. Treatment usually begins once the patient has recovered sufficiently and the oncology team determines that chemotherapy can be safely administered.

How many cycles are required?

The number varies by cancer and regimen. Some programmes involve several cycles over a number of months.

Does it cause hair loss?

It can, but not every chemotherapy regimen causes significant hair loss.

Does chemotherapy cause infertility?

Some chemotherapy drugs can affect fertility. Patients who wish to preserve fertility should discuss this before treatment whenever possible.

Can adjuvant chemotherapy cure cancer?

It can contribute to curative treatment in cancers where postoperative systemic therapy has been shown to reduce recurrence. It cannot guarantee that cancer will not return.

Can it be taken as tablets?

Yes. Some chemotherapy medicines are available orally. Other regimens require intravenous treatment.

Can international patients receive adjuvant chemotherapy in India?

Yes, provided the treating hospital reviews the medical records and determines that the patient is medically suitable. Some patients travel for systemic treatment; feasibility depends on the schedule, medical stability and follow-up plan.

Key takeaways

• GAF Healthcare partner planning for this pathway is $2,500–$10,000, typically cycles after surgery over 3–6 months.
• Neighbouring United States comparison figures are $15,000–$45,000.
• Neighbouring neoadjuvant planning is $2,500–$10,000 for cycles before surgery.
• Adjuvant chemotherapy is not required for every cancer patient.
• The plan depends on pathology, stage, biomarkers and overall health, not on the diagnosis alone.
• Fever during chemotherapy belongs in a local emergency department, not on WhatsApp.
• International patients should obtain a regimen-specific hospital quotation after medical-record review.

Medical disclaimer

This page is intended for educational and treatment-cost planning purposes and should not replace consultation with a qualified oncologist.

Cost figures are indicative and may change according to hospital, city, cancer diagnosis, chemotherapy drug, dose, number of cycles, investigations, specialist fees, admission requirements and other clinical factors.

Treatment decisions should be made after review of the patient's pathology, imaging, medical history and overall condition by an appropriate multidisciplinary cancer team.

Last reviewed: October 2026

Sources and references

1. National Cancer Institute (NCI) — Definition and overview of adjuvant chemotherapy
2. American Society of Clinical Oncology (ASCO) — Evidence-based oncology practice guidelines
3. European Society for Medical Oncology (ESMO) — Disease-specific cancer treatment guidance
4. Indian Council of Medical Research (ICMR) — Indian cancer guidelines
5. World Health Organization (WHO) — Multidisciplinary cancer-treatment principles
6. American Cancer Society — Chemotherapy planning and side-effect information
7. Cancer Research UK — Neoadjuvant and adjuvant chemotherapy explanations
8. GAF Healthcare cost sheet — Adjuvant Chemotherapy ($2,500–$10,000; cycles after surgery · 3–6 months)
9. GAF Healthcare cost sheet — Neoadjuvant Chemotherapy ($2,500–$10,000; cycles before surgery · 2–4 months)
10. GAF Healthcare cost sheet — Chemotherapy ($1,500–$8,000+)

Medical information should be interpreted in the context of current clinical guidelines and the individual patient's diagnosis. Published hospital and provider cost estimates are indicative and can change without notice.